CY1118153T1 - Αγωγη μικροβιακων μολυνσεων - Google Patents
Αγωγη μικροβιακων μολυνσεωνInfo
- Publication number
- CY1118153T1 CY1118153T1 CY20161101085T CY161101085T CY1118153T1 CY 1118153 T1 CY1118153 T1 CY 1118153T1 CY 20161101085 T CY20161101085 T CY 20161101085T CY 161101085 T CY161101085 T CY 161101085T CY 1118153 T1 CY1118153 T1 CY 1118153T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- microbial infections
- mscramm
- relates
- present
- Prior art date
Links
- 230000000813 microbial effect Effects 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αφορά βελτιωμένα εμβόλια μικροβιακού αντιγόνου, φαρμακευτικές συνθέσεις, ανοσογονικές συνθέσεις και αντισώματα και τη χρήση αυτών στην αγωγή μικροβιακών μολύνσεων, συγκεκριμένα αυτών βακτηριακής προέλευσης, συμπεριλαμβανομένης Σταφυλοκοκκικής προέλευσης. Κατά ιδανικό τρόπο, η παρούσα εφεύρεση αφορά ένα ανασυνδυασμένο σταφυλοκοκκικό MSCRAMM ή ομοιάζουσες προς MSCRAMM πρωτεΐνες ή θραύσμα αυτών, με μειωμένη δέσμευση προς τον προσδέτη ξενιστή αυτού για χρήση στη θεραπεία.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE20080070 | 2008-01-31 | ||
GBGB0801768.3A GB0801768D0 (en) | 2008-01-31 | 2008-01-31 | Treatment of microbial infections |
PCT/EP2009/051033 WO2009095453A1 (en) | 2008-01-31 | 2009-01-29 | Treatment of microbial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118153T1 true CY1118153T1 (el) | 2017-06-28 |
Family
ID=40512496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161101085T CY1118153T1 (el) | 2008-01-31 | 2016-10-26 | Αγωγη μικροβιακων μολυνσεων |
Country Status (22)
Country | Link |
---|---|
US (3) | US20110150918A1 (el) |
EP (2) | EP3117832B1 (el) |
JP (1) | JP5709527B2 (el) |
KR (1) | KR101739048B1 (el) |
CN (1) | CN101983067B (el) |
AU (1) | AU2009209598B2 (el) |
BR (1) | BRPI0906997A2 (el) |
CA (1) | CA2713241C (el) |
CY (1) | CY1118153T1 (el) |
DK (1) | DK2244722T3 (el) |
EA (1) | EA019516B1 (el) |
ES (2) | ES2960604T3 (el) |
HR (1) | HRP20161305T1 (el) |
HU (1) | HUE031614T2 (el) |
LT (1) | LT2244722T (el) |
MX (1) | MX2010008423A (el) |
PL (1) | PL2244722T3 (el) |
PT (1) | PT2244722T (el) |
SG (1) | SG188102A1 (el) |
SI (1) | SI2244722T1 (el) |
WO (1) | WO2009095453A1 (el) |
ZA (1) | ZA201005798B (el) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007100580A2 (en) * | 2006-02-22 | 2007-09-07 | The Texas A & M University System | Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
MX2010008423A (es) | 2008-01-31 | 2010-09-22 | Trinity College Dublin | Tratamiento de infecciones microbianas. |
WO2010151544A1 (en) | 2009-06-22 | 2010-12-29 | Wyeth Llc | Immunogenic compositions of staphylococcus aureus antigens |
CN102666583B (zh) | 2009-07-15 | 2015-11-25 | Aimm医疗股份公司 | 革兰氏阳性细菌特异性结合化合物 |
EP2453915B1 (en) | 2009-07-16 | 2017-04-19 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | Treatment of infections |
GB0913680D0 (en) * | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
EP2488547B1 (en) | 2009-10-15 | 2017-12-06 | University Court of the University of Edinburgh | Staphylococcal antigens |
CN101843899B (zh) * | 2010-05-24 | 2012-11-07 | 中国人民解放军第三军医大学 | 耐甲氧西林金黄色葡萄球菌(mrsa)重组多亚单位基因工程疫苗及其制备方法 |
WO2012034067A1 (en) | 2010-09-09 | 2012-03-15 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens |
WO2013159021A1 (en) * | 2012-04-20 | 2013-10-24 | The Texas A&M University System | Engineered collagen binding mscramm with enhanced affinity for collagen |
PL2917360T3 (pl) * | 2012-11-06 | 2020-06-29 | Medimmune, Llc | Przeciwciała dla determinant powierzchniowych S. aureus |
GB201310008D0 (en) | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
EP3229833A1 (en) | 2014-12-10 | 2017-10-18 | GlaxoSmithKline Biologicals SA | Method of treatment |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
GB201802339D0 (en) * | 2018-02-13 | 2018-03-28 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
AU2019258504B2 (en) * | 2018-04-24 | 2020-03-12 | Fibriant B.V. | Therapeutic uses of fibrinogen gamma prime variants |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008341A (en) * | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
WO2000064925A1 (en) * | 1999-04-28 | 2000-11-02 | The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Method of inhibiting leukocyte adhesion to fibrinogen |
CA2351018A1 (en) * | 2001-07-09 | 2003-01-09 | Universite De Sherbrooke | Dna vaccine against staphylococcus aureus |
EP2301957A3 (en) | 2004-05-21 | 2011-05-18 | Wyeth LLC | Altered fibronectin-binding protein of staphylococcus aureus |
MX2010008423A (es) | 2008-01-31 | 2010-09-22 | Trinity College Dublin | Tratamiento de infecciones microbianas. |
-
2009
- 2009-01-29 MX MX2010008423A patent/MX2010008423A/es active IP Right Grant
- 2009-01-29 EA EA201001212A patent/EA019516B1/ru not_active IP Right Cessation
- 2009-01-29 EP EP16173940.4A patent/EP3117832B1/en active Active
- 2009-01-29 PL PL09705327T patent/PL2244722T3/pl unknown
- 2009-01-29 JP JP2010544703A patent/JP5709527B2/ja active Active
- 2009-01-29 WO PCT/EP2009/051033 patent/WO2009095453A1/en active Application Filing
- 2009-01-29 EP EP09705327.6A patent/EP2244722B1/en not_active Revoked
- 2009-01-29 HU HUE09705327A patent/HUE031614T2/en unknown
- 2009-01-29 ES ES16173940T patent/ES2960604T3/es active Active
- 2009-01-29 KR KR1020107019237A patent/KR101739048B1/ko active IP Right Grant
- 2009-01-29 BR BRPI0906997-6A patent/BRPI0906997A2/pt not_active Application Discontinuation
- 2009-01-29 PT PT97053276T patent/PT2244722T/pt unknown
- 2009-01-29 ES ES09705327.6T patent/ES2599953T3/es active Active
- 2009-01-29 SI SI200931536A patent/SI2244722T1/sl unknown
- 2009-01-29 CN CN200980112527.0A patent/CN101983067B/zh active Active
- 2009-01-29 US US12/865,336 patent/US20110150918A1/en not_active Abandoned
- 2009-01-29 DK DK09705327.6T patent/DK2244722T3/en active
- 2009-01-29 LT LTEP09705327.6T patent/LT2244722T/lt unknown
- 2009-01-29 CA CA2713241A patent/CA2713241C/en active Active
- 2009-01-29 AU AU2009209598A patent/AU2009209598B2/en active Active
- 2009-01-29 SG SG2013007786A patent/SG188102A1/en unknown
-
2010
- 2010-08-13 ZA ZA2010/05798A patent/ZA201005798B/en unknown
-
2015
- 2015-05-01 US US14/701,789 patent/US9637525B2/en active Active
-
2016
- 2016-10-10 HR HRP20161305TT patent/HRP20161305T1/hr unknown
- 2016-10-26 CY CY20161101085T patent/CY1118153T1/el unknown
-
2017
- 2017-03-20 US US15/463,665 patent/US11512118B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118153T1 (el) | Αγωγη μικροβιακων μολυνσεων | |
CY1118576T1 (el) | Πρωτεϊνες δεσμευομενες με αντιγονο ανθρωπινης il-23 | |
CY1120144T1 (el) | Αντισωματα αντι-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων | |
CY1122490T1 (el) | Αντισωματα κατα του ανθρωπινου cd38 | |
CY1121632T1 (el) | Η rv2386c πρωτεϊνη φυματιωσης, συνθεσεις και χρησεις αυτης | |
CY1119518T1 (el) | Τροποποιημενα αντιγονα φυματιωσης | |
CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
CY1124412T1 (el) | Aνti-dkk-1 αντισωματα | |
CY1118880T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
ECSP12012272A (es) | Proteínas que se unen al tnf-? | |
BR112013017080A8 (pt) | Anticorpo ou fragmento funcional do mesmo que se liga a forma ativa de calicreína do plasma humano, composiçao farmacêutica e método de detecçao de calicreína do plasma em um paciente | |
CY1120772T1 (el) | ΜΕΤΑΛΛΑΓΜΕΝΑ ΘΡΑΥΣΜΑΤΑ OspA ΚΑΙ ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ ΣΧΕΤΙΚΕΣ ΜΕ ΑΥΤΑ | |
EA201100268A1 (ru) | Вакцина | |
CY1115091T1 (el) | Διειδικες πρωτεϊνες προσδεσης αντιγονων | |
CY1119410T1 (el) | Βελτιστοποιημενα μονοκλωνικα αντισωματα εναντι του αναστολεα της οδου του ιστικου παραγοντα (tfpi) | |
EA201171494A1 (ru) | Миметики белка smac | |
UA113712C2 (xx) | Антитіло до fap і способи його застосування | |
CY1118200T1 (el) | Πολυπεπτιδια, πολυνουκλεοτιδια και συνθεσεις για χρηση στη θεραπεια λανθανουσας φυματιωσης | |
CY1114658T1 (el) | Πρωτεϊνες δεσμευσης αντιγονου του αυξητικου παραγοντα τυπου επιδερμικου αυξητικου παραγοντα προσδεσης στην ηπαρινη | |
BR112014028785A2 (pt) | proteínas de ligação a antígeno de st2 | |
NO20083891L (no) | Anti-5T4 antistoffer og anvendelser derav | |
BRPI0819916A2 (pt) | Proteína de ligação a antígeno, composição farmacêutica, método para tratar um paciente humano afligido com uma doença, anticorpo ou fragmento do mesmo, e, proteína de ligação a antígeno. | |
CY1119737T1 (el) | Νεες συνθεσεις και μεθοδοι | |
CY1113770T1 (el) | Κυκλικα αντι-μικροβιακα πεπτιδια | |
DE602007013618D1 (de) | Antikörper gegen das humane cytomegalie-virus (hcmv) |